Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,294,115
-$3,017,714 QoQ
Shares Held
121,337
-54.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#151
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$339,744,000
PutShares
9,600,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ROIV ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,744,000 | 9,600,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $4,294,115 | 121,337 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,311,829 | 263,965 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $298,764 | 13,768 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $55,722 | 3,683 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $38,970 | 3,458 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,577 | 3,427 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $88,734 | 7,501 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $47,023 | 4,075 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $31,994 | 3,027 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $175,511 | 16,652 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $292,753 | 26,069 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,769,915 | 151,534 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,402,449 | 139,132 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $932,278 | 126,325 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,888 | 737 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,254 | 700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,637 | 648 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,944 | 596 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,927 | 588 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||